The dataset shows a peak of 12 families in 2019 followed by a decline to a midpoint of 5 by 2022, which typically signals that the core claim space — continuous crystallization apparatus and particle-size control processes — was staked out early and later filers found less open territory. It does not necessarily mean interest in the technology itself has declined; it means the patenting of foundational process and apparatus claims has slowed. Companies still active in scale-up work may now be filing narrower process-control or formulation claims that fall outside this dataset's core IPC classes. Readers should also account for publication lag: the final one to two years in any trend understate true filing activity because applications haven't published yet.

The most-cited records in this dataset are continuous crystallizer apparatus patents and particle-size control process patents, several dating to the 1970s through 1990s, including continuous stirred backmixed crystallizer and continuous-stream upflow crystallization apparatus designs. UOP LLC's particle-size and distribution control process is a notable later entrant that builds directly on that older apparatus art. Citation counts here reflect accumulated influence over decades in a searched corpus, so they favour older grants rather than indicating which patents matter most for a filing today. A freedom-to-operate review should check both the original apparatus claims and later refinements layered on top.

Neither dominates outright: this dataset shows 19 records at each of the China and US receiving offices, with Europe, WIPO, Japan and India well behind. That even split suggests scale-up innovation in this space is being commercialised and protected in both major markets rather than concentrated in one. A filer targeting global manufacturing customers should plan for coverage in both jurisdictions rather than treating one as sufficient. Smaller offices like Japan and India show enough activity to warrant a check but not enough to suggest they're primary filing targets on their own.

US6656447B1, assigned to UOP LLC, claims a continuous process for synthesizing molecular sieves across a broad empirical formula spanning silicon, aluminium and phosphorus framework elements, using continuously fed reactive-source streams with interstage backmixing or staging to control particle size and distribution. That breadth means it can read on continuous synthesis processes for a wide range of molecular sieve chemistries, not just one specific framework type, if the particle-size control mechanism matches. Anyone designing a continuous crystallization process for molecular sieves should map their reactor staging and backmixing approach against this claim specifically, alongside the older apparatus patents it builds on. Design-around routes typically involve batch or semi-batch configurations, or particle-size control methods that don't rely on interstage backmixing or stage-count adjustment.

The IPC composition shows scale-up claims are concentrated in core inorganic synthesis (C01B, 69 of 71 records) and catalytic process framing (B01J, 17 records), with only a handful of records touching process control (G05D), grinding integration (B02C) or formulation-adjacent areas (C11D). That leaves in-line process monitoring and control loops, template-free shaped extrudate production, and integration between continuous synthesis and downstream mechanical processing as comparatively thin areas. These are not guaranteed to be open — a full clearance search is still needed — but the filing density relative to the core synthesis claims is visibly lower, which is where a first-filer advantage is more plausible.